OSR (OSRH) Competitors $0.61 +0.04 (+6.51%) As of 10/3/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock OSRH vs. NEPH, NMTC, ZYXI, CLGN, MODD, ECOR, MLSS, POCI, RBOT, and STRRShould you be buying OSR stock or one of its competitors? The main competitors of OSR include Nephros (NEPH), NeuroOne Medical Technologies (NMTC), Zynex (ZYXI), CollPlant Biotechnologies (CLGN), Modular Medical (MODD), electroCore (ECOR), Milestone Scientific (MLSS), Precision Optics (POCI), Vicarious Surgical (RBOT), and Star Equity (STRR). These companies are all part of the "medical equipment" industry. OSR vs. Its Competitors Nephros NeuroOne Medical Technologies Zynex CollPlant Biotechnologies Modular Medical electroCore Milestone Scientific Precision Optics Vicarious Surgical Star Equity Nephros (NASDAQ:NEPH) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Do analysts prefer NEPH or OSRH? Nephros currently has a consensus target price of $5.50, suggesting a potential upside of 15.30%. Given Nephros' stronger consensus rating and higher probable upside, equities analysts plainly believe Nephros is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nephros 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is NEPH or OSRH more profitable? Nephros has a net margin of 7.95% compared to OSR's net margin of 0.00%. Nephros' return on equity of 14.89% beat OSR's return on equity.Company Net Margins Return on Equity Return on Assets Nephros7.95% 14.89% 11.64% OSR N/A -12.19%-8.18% Does the media favor NEPH or OSRH? In the previous week, Nephros had 3 more articles in the media than OSR. MarketBeat recorded 4 mentions for Nephros and 1 mentions for OSR. OSR's average media sentiment score of 1.00 beat Nephros' score of 0.45 indicating that OSR is being referred to more favorably in the news media. Company Overall Sentiment Nephros Neutral OSR Positive Which has stronger earnings & valuation, NEPH or OSRH? Nephros has higher revenue and earnings than OSR. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNephros$14.16M3.57$70K$0.1239.75OSRN/AN/A-$2.41MN/AN/A Do institutionals and insiders hold more shares of NEPH or OSRH? 41.1% of Nephros shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 6.7% of Nephros shares are held by insiders. Comparatively, 60.6% of OSR shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, NEPH or OSRH? Nephros has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, OSR has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. SummaryNephros beats OSR on 9 of the 13 factors compared between the two stocks. Get OSR News Delivered to You Automatically Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSRH vs. The Competition Export to ExcelMetricOSRUNCLASSIFIED IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$13.17M$171.59M$2.51B$10.58BDividend YieldN/AN/A2.52%4.69%P/E RatioN/A2.0226.6426.70Price / SalesN/A49.29119.70229.32Price / CashN/A72.8547.7931.09Price / Book-0.1658.0037.956.57Net Income-$2.41M-$1.39M$6.99M$276.78M7 Day Performance5.14%-0.23%1.91%2.42%1 Month Performance6.09%0.40%3.71%8.63%1 Year PerformanceN/A78.25%64.10%31.60% OSR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSRHOSRN/A$0.61+6.5%N/AN/A$13.17MN/A0.00N/APositive NewsShort Interest ↓Gap UpNEPHNephros2.2618 of 5 stars$4.45+6.5%$5.50+23.6%+201.9%$47.17M$14.16M37.0830News CoveragePositive NewsShort Interest ↑NMTCNeuroOne Medical Technologies2.7851 of 5 stars$0.92+2.2%$2.23+142.1%-3.0%$45.95M$3.45M-6.1320News CoverageAnalyst UpgradeShort Interest ↓Gap UpZYXIZynex2.3157 of 5 stars$1.45-1.4%$4.90+237.9%-81.4%$43.93M$192.35M-1.54770CLGNCollPlant Biotechnologies2.3888 of 5 stars$3.14+11.0%$11.50+266.2%-48.8%$39.93M$510K-2.7870News CoverageGap UpHigh Trading VolumeMODDModular Medical0.4222 of 5 stars$0.70-0.1%N/A-70.4%$38.92MN/A-1.3820Short Interest ↑Gap UpECORelectroCore2.3928 of 5 stars$4.93+2.3%$25.50+417.2%-31.8%$37.39M$25.18M-3.0450MLSSMilestone Scientific2.901 of 5 stars$0.46-1.7%$1.25+171.7%-50.2%$36.76M$9.08M-6.5730POCIPrecision Optics0.7285 of 5 stars$4.39-0.2%N/A-7.8%$33.65M$19.10M-4.9380News CoverageEarnings ReportRBOTVicarious Surgical0.84 of 5 stars$5.46-0.5%$7.00+28.1%+24.3%$32.38MN/A-0.54210STRRStar Equity1.4092 of 5 stars$11.40-0.9%$5.00-56.1%+186.7%$31.41M$140.06M-8.771,300Positive NewsGap Up Related Companies and Tools Related Companies Nephros Alternatives NeuroOne Medical Technologies Alternatives Zynex Alternatives CollPlant Biotechnologies Alternatives Modular Medical Alternatives electroCore Alternatives Milestone Scientific Alternatives Precision Optics Alternatives Vicarious Surgical Alternatives Star Equity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSRH) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OSR Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OSR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
